ReviewBreast cancer (Dove Medical Press)2026
Radiomics and Deep Learning: Bridging Breast Cancer Imaging Phenotypes and Genomic Heterogeneity.
Review in Breast cancer (Dove Medical Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- MRI-based radiomics with SHAP interpretation for preoperative prediction of upstaging in ductal carcinomaTranslational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer is a highly heterogeneous malignancy. Radiomics, combined with deep learning techniques, harnesses the power of advanced medical imaging to extract rich quantitative features that noninvasively capture tumor imaging phenotypes. This approach facilitates the integration of macroscopic imaging data with genomic heterogeneity, thereby bridging the gap between tumor radiographic appearance and underlying molecular profiles. This review systematically outlines the radiomics workflow in breast cancer, encompassing image acquisition, tumor segmentation, feature extraction, feature selection, and modeling strategies. Emphasis is placed on the role of deep learning in automating feature extraction and enabling multimodal data fusion to enhance predictive accuracy. By examining current research progress, we elucidate methods to uncover latent information related to gene mutations, immune microenvironment characteristics, and other genomic alterations from imaging data. This synthesis highlights the potential of radiogenomics to provide novel insights and tools for precision medicine, ultimately fostering personalized diagnosis, prognosis, and treatment planning in breast cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.